The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Most disabled people say they are treated differently by strangers and reveal common gaffes for Scope's #EndTheAwkward campaign.
Ideas are being sought to get more people involved in sport after participation figures fall three years after the London 2012 Olympics.
Scotland's exams body has reassured pupils that "no learner will be disadvantaged" after a backlash against this year's Higher maths exam.